genetics, which could have advanced rapidly with the rediscovery of Mendel's work, failed to achieve this advance until many years later, and there is some irony in the fact that during these wasted years it was the work of the anti-Mendelians that was outstanding.
The clarification of the status of familial disease made available a mass of clinical observations that in turn could elucidate Mendelian principles. Over the years came recognition of the specific problems of Mendelian ratios in the relatively small numbers presented by human families. There also came the concepts of expression and of penetrance, particularly in dominant disorders, and the concepts of incomplete recessiveness and the carrier state. The multiplicity of blood groups brought much elucidation on multiple allelomorphs. The interaction between heredity and environment seen in an extreme form in the fractures induced by minimal trauma in fragilitas ossium could also be seen in more subtle aspects in other disorders, including possibly tuberculosis and other infectious diseases which were operative only in a susceptible genetic constitution. Haemolytic jaundice of infants was seen not to be strictly genetic in character but a form of induced autolysis because of genetic incompatibility.
To-day both the significance and the scope of medical genetics are increasing rapidly. As the infectious diseases are being brought under control, the constitutional factors of disease are once again assuming a dominant place in pathology, and it is becoming increasingly obvious that these are largely determined genetically. Moreover, an extensive range of clinical appearances previously considered environmental in origin have come to be recognized as merely different stages of hereditary diseases which run an evolutionary course in post-natal life and thus present different aspects in different members of a family.
But present-day medical genetics is no longer a matter of collecting and interpreting pedigrees. Statistical methods have made possible the assessment of the frequency of pathogenic genes and of mutation rates in the population, so that genetically determined disease is no longer an altogether unknown quantity. Recognition of the inborn errors of metabolism of Garrod have led to intensive studies of enzyme systems at the cellular level, and there is hope that the uncovering of biochemical faults as the mechanism of genetic disorders may open therapeutic possibilities. Some such possibilities are already being effected, as, for instance, the relative control of galactosaemia by excluding galactose in the infant's food.
Faulty protein synthesis is yet another possible basis of genetic disorders. This is seen most strikingly in the current studies on sickle-cell anaemia and the other haemoglobinopathies, and it is likely that many other hereditary anomalies, including such classical affections as retinitis pigmentosa, may come to be explained in this manner.
Ever since the gene came to be located in the chromosome, the possibility of chromosomal anomalies as a cause of hereditary disease has been under consideration. Until recently such anomalies-observed microscopically-were held to be incompatible with life if they were present in any but a minimal form. It is now clear that chromosomal anomalies are in fact a substantial cause of pathological states. Down's syndrome (mongolism) is an outstanding example.
The gene itself has followed the atom in ceasing to be the irreducible particle of matter. There is evidence that the genewhich may have a thickness of a millionth of a millimetre-is itself a complex of thinner segments each with its specific effect.
The intensive chemical studies on deoxyribose-nucleic acid (D.N.A.) have bearings on both chromosomes and genes.
A Fundamental Problem
The nature of the gene is a problem that goes to the root of all biological thought. Since each cell in the body carries a full complement of chromosomes-so that incidentally each cell in the body is either male or female, and demonstrably so histologically-there must occur in the course of repeated divisions of the fertilized ovum not only development of particular cells giving particular tissues and organs but suppression within such cells of all other potentialities. The puzzle of life therefore begins at a subcellular level, and an understanding of the pathways of gene action has become a fundamental problem in biology, which itself is reaching out towards the control of the energy locked in the gene. To a hypothetical philosophical biologist hereditary diseases represent Nature's experiments in gene action, and as such diseases in man are so intensively studied daily at thousands of centres they would give endless material for genetic investigations, for the study of anomalously acting genes is an excellent exercise in attempts to understand the normal. It is possible that ultimately Mendel's contribution to medicine will be seen to lie not so much in the opening of a new chapter in pathology as in the steering of medicine well into the main stream of biological thought.
Somatic Mutation and Chronic Disease* Sir MACFARLANE BURNET,t-o.M., M.D., F.R.C.P., F.R.S. Brit. med. J., 1965, 1, 338-342 It is common to divide disease into that for which environ- (Armitage and Doll, 1957) . Such an approach to common diseases by a study of the changing incidence with age and sex has been a commonplace of epidemiology in relation to infectious diseases (Burnet, 1952) . If (Burnet, 1959) . The implications of this point of view have recently been examined in mathematical papers by Burch (1963) and Burch and Rowell (1963) , who find that the epidemiology of rheumatoid arthritis and of several other autoimmune diseases is in accord with a model based on the emergence of forbidden clones by a process of somatic mutation. Subsequently Burch has found that similar reasoning applied to the age and sex incidence of both manic-depressive psychosis and schizophrenia points to an " autoimmune " aetiology. Our own interest in the New Guinea disease " kuru " has also been stimulated by the interesting resemblance of the adult age and sex incidence of kuru to that of systemic lupus. It is difficult, however, to believe that schizophrenia and kuru are both autoimmune diseases in any conventional sense.
In considering chronic disease it is impossible not to make some attempt to bring the general question of ageing into the picture. In many ways the major causes of " natural death," cancer, inadequacy of resistance to infection, and cerebral or cardiac accidents associated with vascular disease can probably all be regarded as more or less accidental intensifications of the general ageing process. In recent years there has been much speculation on whether somatic mutation plus secondary autoimmune processes plays a significant part in ageing (see Comfort, 1963) . Perhaps the role of autoimmunity has been overemphasized, but I believe that a strong case can be made for regarding somatic mutation as an important basic factor in ageing.
If ageing and chronic disease are to be regarded in part as the results of somatic mutation it is equally necessary to emphasize the converse of this hypothesis-namely, that there must be an( some highly efficient mechanism by which the germ cells do not age. This is too complex a subject to discuss here. In general terms, we can probably assume that the processes of meiosis and fertilization include an inbuilt scrutiny for chromosomal damage of any sort. In some way there is a high selective advantage in normality for the germ cells. 
Nature of Somatic Mutation
The essence of cell division is the accurate duplication of the whole genetic apparatus, in particular the base-by-base replication of the whole chromosomal deoxyribonucleic acid (D.N.A.) with its contained genetic information. No complex biological process is completely free of the possibility of error. In the case of D.N.A. replication it is almost universally accepted that the possibility of error is the main or only source of the raw material for evolution. In the absence of known mutagenic agents the chance of error at any nucleotide is of the order of 10-8 per replication (Orgel, 1963 However, from our present point of view we are concerned, not with a slow development of functional inadequacy whose only clinical effect is a shortening of the life-span, but with processes manifesting themselves in recognizable disease. We are specially interested in the possibilities of disease mediated by the highly mobile, expendable, and renewable cells of the lymphoid series. Curtis is probably correct that for such cells the average random somatic mutation will result in its rapid competitive elimination. The only significant mutations will be those which, in one way or another, produce a selective proliferative advantage.
Genetic Significance of Differentiation
At this point we may consider briefly the genetic significance of differentiation in relation to the effect of somatic mutation. Every cell capable of growth and replication must retain a large proportion of its genome in functional activity, but since its activities and potentialities are enormously less than those of the fertilized ovum there must also be a large proportion of repressed and non-functional areas. Mutation here will be without detectable effect. Mutation in a functional region will result in some inadequacy, particularly if it occurs in a gene whose allele is genetically aberrant. Whatever the functional effect of a somatic mutation, whether it is lethal to the cell or induces the cell to secrete a toxic product or to cease producing its normal product, there will be no observable effect if this occurs in a single cell among the many million cells in the tissue concerned. With a mutation occurring with a rate of the general order of 10-6 to 10-7 per replication it is never likely to make any direct difference to the functioning of an organ.
It is almost inconceivable that any observable effect will arise from one cell in a million that is out of step with the rest.
The only way in which events of the nature of somatic mutation, " events random in respect of time," can have physiological or pathological effects is by their production of something which as a result of the mutation can increase largely in amount.
The most direct way is that the cell in question should give rise to many more descendants, so that eventually these will form a significantly large fraction of the population; but at least one other mechanism can be imagined. Perhaps the simplest situation is when the somatic mutation occurs during an early stage in the primary segmentation of the ovum. An interesting example of this sort involving " fleece mosaics " in sheep has been described by Fraser and Short (1958 In the clonal selection theory (Burnet, 1959) A forbidden clone is derived from a cell which, because of somatic mutation or its equivalent, can pass the homoeostatic barrier-although it is reactive with a self-component.
The implications of this hypothesis of autoimmune disease include the following, which have been verified either in human material or in the spontaneously autoimmune strain of mice NZB.
1. Cells should be capable of growth in the thymus as well as in spleen or lymph nodes (myasthenia gravis, S.L.E., and NZB mice).
2. Cells should be capable of growth in organs containing the self-antigen concerned (germinal centres and lymph follicles in thyroid).
3. Cytotoxic agents selectively active against proliferating cells should have therapeutic effects (mercaptopurine).
4. Some germinal centres should show evidence of production of a relevant antibody (rheumatoid arthritis).
5. Antibody can be produced against antigenic determinants common to all vertebrates and therefore antigenic (under normal
No other interpretation of autoimmune disease can provide a similarly straightforward interpretation of these findings.
As already mentioned, Burch has used the forbidden-clone concept to interpret the age and sex incidence of rheumatoid arthritis and other autoimmune diseases. I shall discuss this work only briefly and superficially.
By definition, mutations are rare events occurring in body cells in a fashion which is random in relation to time. If such events, either alone or in association with other random or definitive events, give rise to symptoms or disease a more or less characteristic age incidence of the disease in question will be generated.
Burch's contention is that, with adequate mathematical logic, it should be possible to deduce from age-incidence curves the nature of the relationships involved and hence to throw some light on aetiology. His approach seems to be based on the following assumptions:
(a) That there are no effects of environment on the incidence of the condition, or, more strictly, that any such effects are randomly distributed over the whole life-span. (c) That, in general, the initiating event depends on the presence of mutant genes in the individual genome and on the occurrence of somatic mutation in cells of the type concerned. In most instances, more than one somatic mutation is required.
Most human autoimnmune diseases have a higher incidence in women than in men, so they must be related directly or indirectly to the sex chromosomes. Systemic lupus with its predominant impact in young women, according to Burch and Rowell (1963) , requires three mutant genes on the X chromosome and three separate somatic mutations on that chromosome.
I am not competent to criticize Burch's work in detail. One has the impression that the accuracy of the available statistical material is inadequate to justify such precise interpretations, but there can be no possible objection to his main contention that this is a legitimate field for scientific study.
Dr. Holmes and I (1964) otherwise, have become foreign to the body. Since a significant proportion of such mutants would be unduly apt to give rise to malignant disease there is a strong evolutionary reason for the development of such a mechanism. If the existence of the mechanism is admitted there are two ways in which it might influence ageing.
(a) The possibility has often been raised that if antibody or specific cellular activity develops against a modified body component there may develop a capacity to act also against the unmodified component. In other words, autoimmune activity is so initiated and could have correspondingly damaging effects. Elsewhere I have discussed this hypothesis and given reasons for regarding the postulated process as being more characteristic of artificial experimental situations than of natural ones (Burnet, 1963) .
(b) On the forbidden-clone hypothesis, it is not excluded that the mutation giving rise to the pathogenic quality may also change the cells concerned so that they become "recognizably foreign " and therefore capable of provoking an immunological reaction against the clone. This has not been demonstrated in any specific situation, but suggestions of its existence come from various quarters-for example, see Burch (1963) . If the general efficiency of the surveillance mechanism weakens with age, possibly in part with the atrophy of the thymus, we could expect a gdual increase in the number of forbidden clones, perhaps particularly those directed against vascular endotheHum.
Possible Role of the Thymus in Ageing
It is clear that in mammals, at least, the thymus plays a key role in the development of immunity, but we have no real clue to the meaning of its progressive atrophy with age.
Experimental studies in mice recently discussed by Metcalf (1964) indicate that the thymus is an organ which, once established, is remarkably autonomous in retaining size and structure. When infant isologous thymuses are grafted they develop into normally structured organs, although appropriate experiments with chromosomal markers strongly suggest that the whole lymphoid element is within a few weeks completely replaced by host cells. This is, presumably, merely a manifestation of a rapid normal turnover of lymphocytes in the thymus. Under stress the thymus is subject to storms of lymphocytic destruction and repopulation. Following Metcalf (1964) , we can assume that the specific functions of the thymus are controlled by its own reticuloepithelial tissue, including the characteristic P.A.S.-positive phagocytic cells of the cortex. These are the cells which, by hypothesis, produce both the lymphocytosis-stimulating factor of Metcalf and the Mowbray factor which form the " nests " within which lymphocytes proliferate and which control the entry and exit of lymphocytes and stem cells.
I should like to close with the suggestion that when we know more about the thymus we may know more about the mechanism of ageing. We know that the thymus regresses and finally atrophies with age, that it is responsible for the activity of lymphocytes as immunologically competent cells in early life, and that it has important, if incompletely understood, associations with autoimmune disease. I have mentioned already what is now a widely held view, that in early life the thymus is responsible for most of the new immunological patterns that are carried by lymphoid cells, and, what is perhaps an individual belief of my own, that most of the elimination of unwanted forbidden clones also takes place in the thymus during early life.
There are several immunological characteristics of ageing which, though at present based on rather fragmentary evidence, are probably general. The best-established is the increasing inability to respond to a new antigen as the animal ages. This seems to hold in human beings and contrasts with the often improved response of old people against antigens experienced in the past. The second is the increased frequency of autoimmune manifestations in old age and chronic illness. If the existence of a surveillance mechanism is accepted this may in fact be a manifestation of the first disability.
Theoretically there are two ways in which the appearance and proliferation of forbidden clones can be prevented or controlled. The first is by the standard process of elimination of reactive cells at an appropriate stage of physiological immaturity by contact with antigen. The second will be expected if the mutation inducing the forbidden clone simultaneously results in the appearance of a new antigen. This will provoke the appearance of antibody-carrying or antibody-producing cells which will eliminate cells of that clone. In the older animal it may be impossible to produce a range of patterns wide enough to include any capable of developing in this fashion. It is equally possible that in the older organism with absent thymus and relatively inactive lymphoid tissue the first type of control may be ineffective as well.
Only indirectly connected with the phenomena of ageing, but important in the present connexion, is the growing evidence that the thymus may be a target organ in autoimmune disease, notably S.L.E. This is a hypothesis we are trying to explore at the experimental level in NZB mice and their hybrids. If, as we believe, the thymus is an important controlling organ one can conceive the development under some circumstances of a vicious circle which could in acute form present as systemic lupus. The possibility that a slower but self-perpetuating immunological attack on the thymus is associated with and perhaps is partly responsible for normal ageing may be a thought worth following in the future.
Summary
The gist of this review is that somatic mutation appears to be a very important factor in the genesis of a wide variety of chronic disease and in the process of ageing itself.
The nature of somatic mutation (a) in expendable actively replicating cells and (b) in non-replicating tissue cells is discussed and the consequences considered.
Malignant disease is included only en passant but autoimmune disease is discussed extensively from the standpoint of the forbidden-clone hypothesis, which makes it virtually equivalent to conditioned malignancy.
Various possibilities are discussed by which somatic mutation in one or very small numbers of cells may be " magnified" sufficiently to produce demonstrable effects.
There is much to suggest that somatic mutation, particularly as expressed through autoimmune disease, may be of special importance in the process of ageing.
The requirements for an autoimmune theory of ageing are: (1) that forbidden clones capable of minor attack on a variety of tissues may arise with greater frequency with advancing age; and (2) that forbidden clones are themselves subject to partial or complete control and that this control may diminish in effectiveness with advancing age.
